RecruitingNot ApplicableNCT06782867

RNS for Treatment-resistant Obsessive-compulsive Disorder

The Effect of Responsive Neurostimulation (RNS) in Treatment-resistant Obsessive-compulsive Disorder (TR-OCD)


Sponsor

Xuanwu Hospital, Beijing

Enrollment

10 participants

Start Date

Feb 5, 2025

Study Type

INTERVENTIONAL

Summary

The purpose of this study is to investigate the effect of personalized responsive neurostimulation (RNS) therapy guided by stereoelectroencephalography (SEEG) in patients with treatment-resistant obsessive-compulsive disorder (TR-OCD).


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a brain stimulation technique called RNS (responsive neurostimulation) for people with severe, treatment-resistant obsessive-compulsive disorder (OCD). RNS detects abnormal brain activity and delivers a tiny corrective electrical pulse to the brain in real time. **You may be eligible if...** - You are between 18 and 65 years old - You have a confirmed diagnosis of OCD - You have tried at least two SSRIs (each for 3–6 months), high-dose clomipramine (3–6 months), cognitive behavioral therapy (6 months), and antipsychotic medications — none of which worked **You may NOT be eligible if...** - You have other psychotic disorders - You have previously had electroconvulsive therapy (ECT), deep brain stimulation (DBS), TMS, or tDCS - You are at significant risk of suicide Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEResponsive Neurostimulation (RNS)

The RNS lead is stereotactically introduced into the target in the brain and fixed to the skull; the lead is then connected to a neurostimulator implanted subcutaneously in the subclavicular region.


Locations(1)

Xuanwu Hospital, Capital Medical University

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06782867